chimerix inc (CMRX:NASDAQ GM)
Herve Mommeja-Marin M.D.
Vice President of Clinical Research, Chimerix, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Dr. Herve Mommeja-Marin, MD has been Vice President of Clinical Research at Chimerix, Inc., since July 2010. Dr. Mommeja-Marin has over 20 years of global medical and clinical research experience in infectious and respiratory disease and clinical medicine. He was Senior Medical Director, Infectious Diseases, for i3 Research, a contract research organization, where he was the lead therapeutic expert in infectious diseases. His background includes numerous Phase I through ...
2505 Meridian ParkwayPhone: 919-806-1074
Durham, North Carolina 27713
Board Members Memberships*There is no Board Members Memberships data available.
Université Denis Diderot - Paris VII
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Andrew Philip Witty||Chief Executive Officer, Executive Director and Member of Finance Committee|
|Joseph Jimenez MBA||Chief Executive Officer|
|Paul Chaplin MSc, Ph.D.||Chief Executive Officer and President|
Bavarian Nordic A/S
|Peter Mørch Eriksen BBA||Chief Executive Officer and Administration Director|
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|